about
Methyltransferase PRMT1 is a binding partner of HBx and a negative regulator of hepatitis B virus transcriptionAntiviral activity of beta-L-2',3'-dideoxy-2',3'-didehydro-5-fluorocytidine in woodchucks chronically infected with woodchuck hepatitis virusAntiviral activity of Bay 41-4109 on hepatitis B virus in humanized Alb-uPA/SCID miceShort peptide nucleic acids (PNA) inhibit hepatitis C virus internal ribosome entry site (IRES) dependent translation in vitro.Interactions between hepatitis B virus and aflatoxin B(1): effects on p53 induction in HepaRG cells.Proinflammatory cytokine TNF-α increases the stability of hepatitis B virus X protein through NF-κB signaling.The HepaRG cell line: biological properties and relevance as a tool for cell biology, drug metabolism, and virology studies.Effects of the TP53 p.R249S mutant on proliferation and clonogenic properties in human hepatocellular carcinoma cell lines: interaction with hepatitis B virus X protein.Control of hepatitis B virus replication by innate response of HepaRG cells.Persistence of the hepatitis B virus covalently closed circular DNA in HepaRG human hepatocyte-like cells.Proteomic analysis of HepaRG cells: a novel cell line that supports hepatitis B virus infection.Hepatitis B virus X protein affects S phase progression leading to chromosome segregation defects by binding to damaged DNA binding protein 1.Initiation of hepatitis B virus genome replication and production of infectious virus following delivery in HepG2 cells by novel recombinant baculovirus vector.Potent nonclassical nucleoside antiviral drugs based on the N,N-diarylformamidine concept.Identification of antigenic regions of duck hepatitis B virus core protein with antibodies elicited by DNA immunization and chronic infection.A novel vector for the study of hepatitis delta virus replication.Phosphorylation of DHBV pre-S: identification of the major site of phosphorylation and effects of mutations on the virus life cycle.HBx relieves chromatin-mediated transcriptional repression of hepatitis B viral cccDNA involving SETDB1 histone methyltransferase.Inhibition of human and woodchuck hepatitis virus DNA polymerase by the triphosphates of acyclovir, 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodocytosine and E-5-(2-bromovinyl)-2'-deoxyuridine.Synthesis and antiviral activity of new carbonylphosphonate 2',3'-dideoxy-3'-thiacytidine conjugates.A cyclic PNA-based compound targeting domain IV of HCV IRES RNA inhibits in vitro IRES-dependent translation.Clinical relevance of the detection of hepatitis delta virus RNA in serum by RNA hybridization and polymerase chain reaction.Initial amplification of duck hepatitis B virus covalently closed circular DNA after in vitro infection of embryonic duck hepatocytes is increased by cell cycle progression.Could hepatitis-B-like non-A non-B hepatitis simply be seronegative hepatitis B?Are 5'-O-carbamate-2',3'-dideoxythiacytidine new anti-HIV and anti-HBV nucleoside drugs or prodrugs?In vitro characterization of viral fitness of therapy-resistant hepatitis B variants.Use of the cross-reactivity between hepatitis B and non-A, non-B viruses for the identification and detection of non-A, non-B 'e' antigen.Therapeutic activity of vidarabine in symptomatic chronic active hepatitis related to HBV.Hepatitis B virus X protein stimulates gene expression selectively from extrachromosomal DNA templates.Hepatitis B virus X protein is essential to initiate and maintain virus replication after infection.Evolution of hepatitis B virus polymerase gene sequence during famciclovir therapy for chronic hepatitis B.The SATE pronucleotide approach applied to acyclovir: part II. Effects of bis(SATE)phosphotriester derivatives of acyclovir on duck hepatitis B virus replication in vitro and in vivo.Analysis of a hepatitis delta virus isolate from the Central African Republic.Identification and detection of long incubation non-A, non-B hepatitis virus and associated antigens or antibodies.Use of the cross-reactivity with hepatitis B virus antigens and antibodies for the demonstration of a woodchuck hepatitis virus 'e' antigen-antibody system.Woodchuck hepatitis virus infection: serologic and histopathologic course and outcome.Main properties of duck hepatitis B virus DNA polymerase: comparison with the human and woodchuck hepatitis B virus DNA polymerases.Effects of 2'-fluorinated arabinosyl-pyrimidine nucleosides on duck hepatitis B virus DNA level in serum and liver of chronically infected ducks.Viral spliced RNA are produced, encapsidated and reverse transcribed during in vivo woodchuck hepatitis virus infection.Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
P50
Q24634260-41844A94-1F34-4CB2-AF54-1A9FA282577BQ28360714-FB0A46D5-43B7-4444-9866-86582A097E13Q34097557-C9EE5DCB-9BCC-4F90-85AA-1BF87AAE20C8Q38289279-34074393-AE58-4989-AC2E-D3B064B00201Q39438020-CD39903F-06EF-45F7-ADE6-D46AAEADE1CDQ39565600-3F8D951F-2AF0-489C-97CB-4C6DEC68B95EQ39678141-11F08A78-B89D-47C8-ABA6-6A63B90B0BDEQ39694595-72D9109A-5738-49E7-8400-4F1369D38258Q39781596-3AD60995-9837-486C-8A74-084FD6A0CA99Q39904503-E2DCAD59-87EE-4191-B23C-DE7696C45850Q39909205-904F4D58-21EE-4E5A-BED8-85DA79620B9DQ39941606-3D12E17D-F1FB-4A69-810D-D1E19AF61BEBQ39960548-4C87457A-3AE5-42B6-A7DC-AAF60DD41D99Q40588334-6BB02FA8-F5F3-4E35-B919-69D51ABAEEBFQ40677965-57CCB965-CFB7-4B00-93B7-C5D7EC283C45Q41059529-4A778B1C-DAEA-4956-A65B-B3BF3A5DAD0EQ41059661-2EA65DBD-7CA7-4BDC-83F2-B70D302F77CCQ41122308-9D96C2F3-904A-499A-80DD-9D9C51F0DC1CQ42251745-D016A67C-6D41-428A-96A6-683240C7D225Q42280653-0421EC64-3A51-4511-A279-39B8209DCB21Q42994145-700E809A-5BCE-47C3-83DB-9E7E1682CC25Q43405027-AA3B588C-13F6-4965-8821-7BC5CEE5161BQ43657705-A8F2CE9C-DB69-40EF-BC7E-3DA0323152CFQ44329190-C91A945B-55AE-4465-8E02-A24DC633CAFBQ44508022-306D22AB-47A8-4512-9ACF-2F43CEFA35FCQ44688075-21E06001-A2F3-4FFD-AB6B-8215F49B60B8Q45216529-DF2C63F6-732E-4FCA-BAA9-4D94C3E1DE39Q45281175-5D867791-0246-448A-8834-DA7A39568081Q45356502-CFA25249-5D4C-4B45-B547-D9813B4E1FEDQ45368504-B64670F6-3FC2-45AA-8ED4-A43750AA490AQ45743184-9B944024-EEA0-4A52-BB49-42737B9112FDQ45751134-040461F4-CA11-4E26-93DB-B73016DCD4A0Q45754176-C5DA6FFE-E4C0-43D1-A10B-2BC4710B6FFBQ45794333-894EA0A0-B7AB-4137-ACF5-9950EF5850BFQ45795114-9BEA0CD6-5C11-4B7E-AF86-5AF62137E643Q45828161-11970914-B7BF-45F2-92B8-BCAA4A4D8176Q45831638-62288AA7-C2D9-45AF-B470-1E2C3CA2F68FQ45865049-133CABAF-6D7C-4324-87A9-6E13592D2AF2Q45872587-4265F7FB-BB24-4B30-9A0F-8BB0FE0900FDQ53637892-9EFB72A5-39D1-4523-A1B3-E08B231F200C
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Olivier Hantz
@ast
Olivier Hantz
@en
Olivier Hantz
@es
Olivier Hantz
@nl
Olivier Hantz
@sl
type
label
Olivier Hantz
@ast
Olivier Hantz
@en
Olivier Hantz
@es
Olivier Hantz
@nl
Olivier Hantz
@sl
prefLabel
Olivier Hantz
@ast
Olivier Hantz
@en
Olivier Hantz
@es
Olivier Hantz
@nl
Olivier Hantz
@sl
P106
P1153
7003709780
P21
P31
P496
0000-0002-1170-6186